Quest Diagnostics Incorporated

NYSE DGX

Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2024: USD 1.40 B

Quest Diagnostics Incorporated Operating Cash Flow is USD 1.40 B for the Trailing 12 Months (TTM) ending September 30, 2024, a 29.47% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 1.08 B, a -42.14% change year over year.
  • Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 1.86 B, a -18.67% change year over year.
  • Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 2.29 B, a 26.55% change year over year.
  • Quest Diagnostics Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 1.81 B, a 52.27% change year over year.
Key data
Date Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid
Market news
Loading...
NYSE: DGX

Quest Diagnostics Incorporated

CEO Mr. James E. Davis
IPO Date Dec. 17, 1996
Location United States
Headquarters 500 Plaza Drive
Employees 50,000
Sector Industrials
Industries
Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Similar companies

IDXX

IDEXX Laboratories, Inc.

USD 418.63

-0.94%

ICLR

ICON Public Limited Company

USD 200.24

-8.14%

SHC

Sotera Health Company

USD 12.76

-2.52%

RVTY

Revvity, Inc.

USD 120.73

-1.61%

IQV

IQVIA Holdings Inc.

USD 197.96

-3.26%

A

Agilent Technologies, Inc.

USD 143.43

1.04%

CRL

Charles River Laboratories International, Inc.

USD 178.08

-6.34%

WAT

Waters Corporation

USD 404.93

1.26%

TWST

Twist Bioscience Corporation

USD 42.75

-1.91%

MTD

Mettler-Toledo International Inc.

USD 1.27 K

0.33%

StockViz Staff

January 15, 2025

Any question? Send us an email